Paymentus Holdings, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Paymentus Holdings, Inc. announced robust second quarter 2026 financial results, featuring a 28.8% year-over-year revenue increase and record adjusted EBITDA margin.
NYSE
Paymentus Holdings, Inc. announced its second quarter 2026 financial results, showcasing a 28.8% year-over-year revenue increase and a record adjusted EBITDA margin of 41.3%.
NYSE
Paymentus Holdings, Inc. has amended its prior 8-K filing to formally disclose its decision to hold future advisory votes on executive compensation annually, following stockholder preference.
NYSE
Paymentus Holdings announced the resignation of director Adam Malinowski and the immediate appointment of Gregory Williams to fill the vacancy.
NYSE
Paymentus Holdings, Inc. stockholders elected directors, ratified auditor appointment, and approved executive compensation and vote frequency at the 2026 Annual Meeting.
NYSE
Paymentus Holdings, Inc. announced robust first-quarter 2026 financial results, showcasing significant year-over-year growth in revenue, contribution profit, and adjusted EBITDA.
NYSE
Paymentus Holdings, Inc. announced the grant of 480,000 restricted stock units to CEO Dushyant Sharma, with a vesting schedule extending to May 2031.
NYSE
Paymentus Holdings, Inc. announced that Andrew Gerber, its General Counsel and Corporate Secretary, will depart the company on April 6, 2026.
NYSE
Paymentus Holdings, Inc. has adopted its 2026 Executive Incentive Compensation Program and approved significant RSU grants for key officers and employees, linking compensation to financial and individual performance.
NYSE
Paymentus Holdings, Inc. reported record fourth quarter and full year 2025 financial results, surpassing expectations with significant revenue and profit growth.
NYSE
Paymentus Holdings, Inc. announced record third-quarter 2025 financial results, driven by significant revenue and adjusted EBITDA growth.
NYSE
Paymentus Holdings, Inc. reported strong second quarter 2025 financial results, with record revenue of $280.1 million and adjusted EBITDA up 40.7% year-over-year, exceeding expectations.
NYSE
Paymentus Holdings, Inc. has awarded its President and CEO, Dushyant Sharma, 1,100,000 time-based restricted stock units to enhance retention and align his financial interests with stockholders.
NYSE
Paymentus Holdings, Inc. announced the successful election of two Class I Directors and the ratification of PricewaterhouseCoopers LLP as its independent auditor at its 2025 Annual Meeting of Stockholders.
NYSE
Paymentus Holdings, Inc. announced a robust start to 2025, with a significant increase in revenue and adjusted EBITDA for the first quarter.
NYSE
Paymentus Holdings, Inc. has adopted the 2025 Executive Incentive Compensation Program and approved bonus payouts for 2024, including a discretionary bonus for the Chief Commercial Officer.
NYSE
Paymentus Holdings, Inc. announces robust financial performance for Q4 and full year 2024, with significant revenue growth and increased profitability.
NYSE
Paymentus Holdings, Inc. announced a 51.9% year-over-year increase in revenue and a 58.2% increase in adjusted EBITDA for the third quarter of 2024.
NYSE
Paymentus Holdings announced a strong second quarter of 2024, with revenue up 32.6% year-over-year and adjusted EBITDA up 58.6%.
NYSE
Paymentus Holdings held its 2024 Annual Meeting, electing three Class III Directors and ratifying PricewaterhouseCoopers LLP as its independent auditor for the fiscal year ending December 31, 2024.
NYSE
Paymentus Holdings, Inc. announced a robust first quarter of 2024, highlighted by a 24.6% year-over-year increase in revenue and a 135.5% surge in adjusted EBITDA.
NYSE
Paymentus Holdings has adopted its 2024 Executive Incentive Compensation Plan and approved bonus payouts for 2023 performance, including a discretionary bonus for the CEO.
NYSE
Paymentus reported a 24.7% year-over-year increase in quarterly revenue and a 95.4% increase in adjusted EBITDA, surpassing original expectations.